TENS and Opioid Use After Cesarean Delivery
Stopped early · Not applicable
Conditions studied: Cesarean Section Complications, Opioid Use
In brief
We propose to explore the effects of Transcutaneous Electrical Nerve Stimulation (TENS) therapy in the pain management of postpartum women. A. Objectives * To determine if the addition of TENS therapy to the pain management of women post-cesarean section leads to less opioid medication use. * To evaluate the efficacy of TENS therapy as a means of alternative pain relief for women post-cesarean section with a history of opioid use. B. Hypotheses / Research Question(s) We hypothesize that patients that receive TENS therapy will report lower pain scores and request less opioid medication than the control group. We anticipate improved control in particular in the group of women with a history of opioid use. Additionally, we believe that the TENS therapy will show benefits in other postpartum outcomes including time to bowel movement, level of sedation, and time to out of bed. Overall, we anticipate that this pilot study will support the application of TENS therapy in postpartum pain management.
Key facts
- Study ID
- NCT03843788
- Run by
- Rutgers, The State University of New Jersey
- People needed
- 16
- Starts
- 2018-11-09
- Expected to finish
- 2020-03-31
- Last updated by the study team
- 2024-10-29
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Women aged between 18 and 45 years
- Understand and be able to follow written and oral instructions in English
- Provide written informed consent
- History of prior opioid addiction for half of the patients.
You may not qualify if…
- History of cardiac arrhythmia or pacemaker usage
Where it is running
- Robert Wood Johnson University Hospital — New Brunswick, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.